Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNLCT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,549
Award facts
- Contract value 100% obligated
- $31,549.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,549.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens, 2 mL formulation. The order, which serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal pharmaceutical procurement requirements.
As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal agencies. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, and its procurement through the DLA supply chain ensures availability for service members and beneficiaries requiring this specialized therapeutic treatment. The firm fixed pricing structure and rapid completion timeline demonstrate the efficiency of leveraging the existing IDC vehicle to fulfill urgent pharmaceutical requirements within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNLCT?
SPE2DB25FNLCT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FNLCT worth?
The government has obligated $31,549 on SPE2DB25FNLCT.
Is contract SPE2DB25FNLCT an order under another contract?
Yes. SPE2DB25FNLCT is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNLCT competed?
The extent of competition for SPE2DB25FNLCT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award